Skip to content
akaturk Academic measurement
2024 SJR Q3 JCR Q1 · 9,4 OA 14 matched articles

Journal detail

European Journal of Cancer, Supplement

Publisher
Elsevier Ltd
Country
United Kingdom · Western Europe
Type
journal
ISSN
  • 13596349
  • 18781217
Scopus 0,428 SJR
Scopus Q3 SJR Q
WoS Q1 JCR Q
WoS 9,4 JIF
Scopus 30 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,428
  • Quartile Q3
  • H-Index 30
  • Cites/doc 0
  • Docs (3y) 3
  • Cites (3y) 2

Clarivate

Web of Science · JCR · 2010

  • JCR Q Q1
  • JIF 9,4
  • 5Y JIF 3,8
  • JCI

Subject classification

Categories (SJR)

  • Cancer Research Q4
  • Oncology Q3

Areas

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2024 Q3 0,428 30
2023 Q2 0,759 30
2022 Q3 0,571 30
2021 Q4 0,248 30
2020 30
2019 Q3 0,383 30
2017 Q1 1,358 30
2016 Q2 0,942 30
2015 Q3 0,221 30
2014 Q4 0,136 30
2013 Q4 0,138 30
2012 Q3 0,363 30
2011 Q3 0,24 30
2010 Q3 Q1 0,217 9,4 3,8 30
2009 Q2 2,7 2,6
2008 Q2 3,4 2,4
2007 Q2 2,7
2006 Q3 2,4
2005 Q2 3,4
2004 Q1 9

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2010 ONCOLOGY SCIE Q1 9/185
2009 ONCOLOGY SCIE Q2 71/166
2008 ONCOLOGY SCIE Q2 53/143
2007 ONCOLOGY SCIE Q2 61/132
2006 ONCOLOGY SCIE Q3 64/127
2005 ONCOLOGY SCIE Q2 44/123
2004 ONCOLOGY SCIE Q1 7/123